Compositions and methods for treating Alzheimer's disease and Parkinson's disease
US10973784B2 · kind B2 · utility
0Cited by
5References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 16, 2019 |
| Grant date | Apr 13, 2021 |
| Priority date | — |
| Expiry date | Jan 16, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to tablets for oral administration to a subject, comprising a therapeutically effective amount of SYN120 or a pharmaceutically acceptable salt thereof, wherein the tablet is substantially free of lactose. The present invention is also directed to methods for treating diseases or conditions including Alzheimer's disease and/or Parkinson's disease, comprising administering to a patient in need thereof tablets regarding the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.